These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 24012635

  • 1. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
    Higashimoto Y, Matsui T, Nishino Y, Taira J, Inoue H, Takeuchi M, Yamagishi S.
    Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
    [Abstract] [Full Text] [Related]

  • 2. In vitro selection of DNA aptamers that block toxic effects of AGE on cultured retinal pericytes.
    Higashimoto Y, Yamagishi S, Nakamura K, Matsui T, Takeuchi M, Noguchi M, Inoue H.
    Microvasc Res; 2007 Jul; 74(1):65-9. PubMed ID: 17493639
    [Abstract] [Full Text] [Related]

  • 3. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
    Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Fukami K, Okuda S, Imaizumi T.
    Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
    [Abstract] [Full Text] [Related]

  • 4. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H.
    Biochem J; 2003 Mar 15; 370(Pt 3):1097-109. PubMed ID: 12495433
    [Abstract] [Full Text] [Related]

  • 5. Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE.
    Matsui T, Oda E, Higashimoto Y, Yamagishi S.
    Cardiovasc Diabetol; 2015 Jan 08; 14():1. PubMed ID: 25582325
    [Abstract] [Full Text] [Related]

  • 6. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.
    Okamoto T, Yamagishi S, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S, Yoshimura A, Makita Z.
    FASEB J; 2002 Dec 08; 16(14):1928-30. PubMed ID: 12368225
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase.
    Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S.
    Horm Metab Res; 2013 May 08; 45(5):387-90. PubMed ID: 23225247
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.
    Ishibashi Y, Matsui T, Maeda S, Higashimoto Y, Yamagishi S.
    Cardiovasc Diabetol; 2013 Aug 28; 12():125. PubMed ID: 23984879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A, Matsui T, Higashimoto Y, Yamagishi SI.
    Diab Vasc Dis Res; 2019 Nov 28; 16(6):556-561. PubMed ID: 31375034
    [Abstract] [Full Text] [Related]

  • 15. Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes.
    Yamagishi S, Amano S, Inagaki Y, Okamoto T, Koga K, Sasaki N, Yamamoto H, Takeuchi M, Makita Z.
    Biochem Biophys Res Commun; 2002 Jan 25; 290(3):973-8. PubMed ID: 11798169
    [Abstract] [Full Text] [Related]

  • 16. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
    Maeda S, Matsui T, Ojima A, Takeuchi M, Yamagishi S.
    Nutr Res; 2014 Sep 25; 34(9):807-13. PubMed ID: 25241332
    [Abstract] [Full Text] [Related]

  • 17. Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration.
    Chibber R, Molinatti PA, Kohner EM.
    Cell Mol Biol (Noisy-le-grand); 1999 Feb 25; 45(1):47-57. PubMed ID: 10099839
    [Abstract] [Full Text] [Related]

  • 18. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells.
    Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H.
    Diabetologia; 1998 Dec 25; 41(12):1435-41. PubMed ID: 9867210
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.